The Henry Samueli School of Engineering Welcomes Three New Faculty Members
|
It is with pleasure that we introduce three new faculty members: Dr. Tibor Juhasz - Professor, Biomedical EngineeringDr. Juhasz joins UC Irvine from the Department of Biomedical Engineering at the University of Michigan. While there, he developed a highly successful research program centered on femtosecond laser applications for Ophthalmological problems. His discoveries led to the formation of Irvine-based IntraLase Corporation -- a company whose laser technique is the base technology used to create the corneal flap in the LASIK procedure. His research interests include laser-tissue interactions, medical applications of lasers, tissue biomechanics, laser science, design of medical laser systems, biomedical imaging, interaction of laser light with matter, optoelectronics and solid state physics. Dr. Juhasz received his Ph.D. in physics from JATE University of Szeged, Hungary in 1986. He also holds a split appointment with the Department of Ophthalmology in the College of Medicine.
Dr. Regina Ragan - Assistant Professor, Chemical Engineering and Materials SciencePrior to joining UC Irvine, Dr. Ragan was a postdoctoral scholar at Hewlett Packard where she conducted research on synthesis and characterization of organic and inorganic nanostructures on solid substrates. Before her time at HP, Dr. Ragan was a graduate research associate at the California Institute of Technology where she studied fabrication of Group IV silicon-compatible nanostructures in order to engineer optical and electrical properties. Dr. Ragan received her Ph.D. in applied physics from Caltech in 2002. She also holds a master's degree in applied physics from Caltech and a bachelor's degree in material science and engineering from the University of California, Los Angeles.
Dr. Szu-Wen Wang - Assistant Professor, Chemical Engineering and Materials ScienceDr. Wang has been with UC Irvine as a post-doctoral researcher since 2003. Most recently, Dr. Wang was a senior scientist of formulation design at TransForm Pharmaceuticals. While there she conducted research which defined and characterized in vitro cell-based drug transport assays, developed a series of automated assays for identification of optimized drug formulations and created formulations for anti-cancer and anti-fungal drugs. Dr. Wang received her Ph.D. in chemical engineering from Stanford University in 1999. She also holds a master's degree in chemical engineering from Stanford University and a bachelor's degree in chemical engineering from the University of Illinois, Urbana-Champaign. |
